Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sorrento becomes one-stop ADC shop with $11.6m Concortis buy

This article was originally published in Scrip

Executive Summary

The recent spending spree by Sorrento Therapeutics has come to an end with the acquisition of Concortis BioSystems whose linkers and cytotoxic agents will be combined with antibodies from Sorrento's G-MAB library to create a one-stop antibody-drug conjugate (ADC) shop.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC023463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel